FIELD: medicine, in particular peroral pharmaceutical composition in form of emulsion precursory concentrate.
SUBSTANCE: claimed composition contains compound of formula I 1 and one or more non-ionic surfactant, wherein said composition forms in situ oil-in-water emulsion under contact with aqueous media, such as gastrointestinal fluids. Also disclosed are standard pharmaceutical form filled with said pharmaceutical composition; peroral emulsion, containing said pharmaceutical composition; as well as methods for treatment of pain and inflammations by administration of said pharmaceutical composition to patient.
EFFECT: composition with high bioavailability of active ingredient, excellent self-emulsified properties without addition of supplementary oily component and only in presence of small amount of surfactant.
28 cl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
NEW SELF-EMULSIFYING SYSTEM FOR DELIVERY OF DRUGS | 2001 |
|
RU2270675C9 |
PHARMACEUTICAL COMPOSITION OF NITROXY DERIVATIVE NONSTEROID ANTI-INFLAMMATORY DRUGS | 2006 |
|
RU2406482C2 |
SOLID PHARMACEUTICAL COMPOSITION CONTAINING BENZOFURAN DERIVATIVES | 1998 |
|
RU2191578C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING DERIVATIVES OF N-SULFONYLINDOLINE | 1997 |
|
RU2174394C2 |
ORALLY ADMINISTRATED LIQUID COMPOSITIONS COMPRISING GUAIFENESIN AND POLYOXYALKYLENE BLOCK-COPOLYMERS | 2002 |
|
RU2281087C2 |
ANTIFUNGAL COMPOSITE WITH ENHANCED BIOAVAILABILITY | 1997 |
|
RU2207119C2 |
COMPOSITIONS OF THE COMPLEXES OF OMEGA-3 FATTY ACIDS | 2013 |
|
RU2633862C2 |
SELF-EMULSIFYING COMPOSITION FOR SCARCELY WATER-SOLUBLE MEDICAMENT | 1999 |
|
RU2257917C2 |
LIPID COMPOSITIONS OF RACECADOTRIL | 2013 |
|
RU2632441C2 |
RACECADOTRIL LIPID COMPOSITIONS | 2014 |
|
RU2662069C2 |
Authors
Dates
2006-05-10—Published
2001-03-06—Filed